In addition, statins can promote the activation and recruitment of APCs and tumor-specific CD8+ T cells in tumor tissues and draining lymph nodes, further enhancing the sensitivity of immune effector cells to ICD-related markers (Kwon et al., 2021). This evidence concerns the gene CD8A and neoplasm.